Home
Conducting Clinical Trials in Europe
12 October - 13 October 2009
Conducting Clinical Trials in Europe

With six previous years of success, SAE Media Group are once again bringing together the leading professionals involved in the field of the clinical research for the annual conference on Conducting Clinical Trials in Europe.

This year’s meeting will include a breadth of issues surrounding the conduct of clinical trials in Europe, with particular focus on the use of emerging markets in tight economic times and pharmacovigilance. With input from major European experts, delegates will be provided with the opportunity to develop their perspective and share their opinions with one another on the most pressing issues within and around the field of clinical trials.

In the light of the current economic climate, the ongoing involvement of emerging markets in clinical research is more necessary than ever and this conference will address the details of clinical trials in emerging markets with some emphasis. Areas to be explored within the field of emerging markets include patient recruitment rates and operating models.

This event is a must for professionals wanting to listen to informed presentations on all aspects of clinical trials, from the orphan drug regulation to the use of modelling and biostatistics in patient recruitment, it will cater for the needs of all people involved in clinical trials.
 

Jacek Nowak, Executive Medical Director, Eastern Europe, Amgen
Barbara Valenta, Senior Director Global Clinical Operations & Global Clinical and Medical Affairs, Baxter

SMi provide a wide range of conference documentation which allows you to benefit from the invaluable information shared by our expert speakers now and in the future. Our Hard Copy Documentation and CD ROMs, PLUS NEW CD Collections provides you with timely information valuable to your industry, which can be used as a future reference tool. Our conference fee includes a copy of the event proceedings in both hard copy and CD ROM.

 

CD Collections

SMi are proud to present our Clinical Trials Collection CD ROM. It will provide you with all the latest information on this subject, plus allows you to look back over the previous year's developments.

 This collection includes:

  • Clinical Trial Logistics 2009
  • Clinical Trials in Cancer 2009
  • Paediatric Clinical Trials 2009
  • Conducting Clinical Trials in Europe 2008
  • Clinical Trials in CNS 2008

Purchase this collection and benefit from having 5 events on 1 disc and a 20% saving.
 

Conference agenda

clock

8:30

Registration & Coffee

clock

9:00

Welcome & Introductions

clock

9:10

The Stages of Drug Development

  • When does Safety begin?
  • What is involved in Safety Monitoring?
  • Serious and non-serious events or reactions, expected or unexpected
  • Drug Safety and risk/benefit
  • clock

    9:50

    Writing Safety Information into the Investigator Brochure

  • Regulations concerning Investigators Brochures (IBs) and Safety Data
  • Pre-Clinical Data & Relevance to the IB
  • Writing Safety Information into the IB
  • Presentation of Safety Data in the IB
  • Updating the IB – When and How?
     
  • clock

    10:30

    Coffee Break

    clock

    10:50

    Expedited Reporting in Clinical Trials

  • ICH Regulations for expedited reporting in clinical trials
  • EU Safety reporting in clinical trials
  • Safety reporting when the product is already marketed
  • CIOMS VI and Safety reporting
  • clock

    11:30

    Periodic Safety Reporting in Clinical Trials

  • Periodic reports to Ethics Committees
  • Annual Safety Reports in the EU & USA
  • Developmental Safety Update Reports
  • clock

    12:10

    Questions and Answers Session

    clock

    12:30

    Close of Workshop

    clock

    8:30

    Registration & Coffee

    clock

    9:00

    Chairman's Opening Remarks

    Jacek Nowak

    Jacek Nowak, Executive Medical Director, Eastern Europe, Amgen

    clock

    9:10

    KEYNOTE PRESENTATION: EMERGING MARKETS

    Jacek Nowak

    Jacek Nowak, Executive Medical Director, Eastern Europe, Amgen

  • Recruitment rates
  • Efficiency metrics
  • Opportunities for strategic partnership
  • Operating models in emerging markets
  • Focus on Eastern Europe
  • clock

    9:50

    TRENDS OF THE USE OF EMERGING MARKETS IN CLINICAL TRIALS

    John Bolodeoku

    John Bolodeoku, Vice President Medical Affairs & Health Economics Europe, Astellas

  • The evolution of the use of emerging markets
  • Current patterns and trends
  • What can we expect in the future?
  • Astellas' experiences of emerging market use
  • clock

    10:30

    Morning Coffee

    clock

    11:00

    SHIFTING SANDS OF THE CLINICAL TRIALS LANDSCAPE

    Dennis Joseph

    Dennis Joseph, Area Head, Country Clinical Operations, Pfizer

  • Why bother? Isn’t big beautiful?
  • What will the new footprint look like?
  • How is the new look being achieved and where are we right now?
  • How well are our new feet working?
  • clock

    11:40

    ONE SIZE DOES NOT FIT ALL

    Rob Laurens

    Rob Laurens, Associate Director, Strategy and Consultation Group, BBK Worldwide

  • Learn how each country's healthcare system, treatment and referral patterns, patient and physician attitudes, demographic and disease prevalence data, and other key variables affect patient recruitment
  • Learn how to weigh collected data in order to rank countries by recruitment suitability
  • Discuss research methods and techniques for determining key recruitment drivers for a given protocol
  • Learn how to evaluate these recruitment drivers, how to recognise the factors that can result in vastly different recruitment potentials in different countries for the same clinical protocol, and what you can do to overcome the recruitment barriers facing a given protocol
  • clock

    12:20

    Networking Lunch

    clock

    13:50

    DEVELOPMENTS IN RETENTION

    J. Findlay Walker

    J. Findlay Walker, Vice President, Daiichi Sankyo Development

  • Tried and true methods
  • Innovative follow-up techniques
  • Harnessing the power of the internet
  • Minimising lost to follow up
  • clock

    14:30

    MEDICAL MONITORING FOR CLINICAL TRIALS

    Fez Hussain

    Fez Hussain, Senior Director, Medical & Scientific Services, Quintiles

  • Safety first!
  • The role of the medic
  • Laboratory surveillance
  • Does geography matter
  • A regulatory perspective through a medic's eyes
  • clock

    15:10

    Afternoon Tea

    clock

    15:40

    EFFECTIVE TRIAL MANAGEMENT IN SHIFTING TO THE FULLY OUTSOURCED MODEL

    Michael Engsig

    Michael Engsig, Senior Director, Head of Clinical Operations , Nycomed

  • Changing mindset
  • Core compentences of the future CTM
  • Process re-engineering
  • clock

    16:20

    PERI-APPROVAL DEVELOPMENT STRATEGY

    Robert Miller

    Robert Miller, Chief Medical Officer, Fulcrum Pharma

  • Peri-approval studies can be a powerful life-cycle tool
  • They represent a good opportunity to raise awareness of a product and allows close collaboration with marketing companies
  • Uncontrolled they can become cumbersome and uninformative
  • Forward planning can provide an enhanced and meaningful programme fully in line with the company’s objectives
  • By this means the drug champion and the therapeutic influencers can be an important part of the life-cycle management  
  • clock

    17:00

    Chairman’s Closing Remarks and Close of Day One

    clock

    8:30

    Registration & Coffee

    clock

    9:00

    Chairman's Opening Remarks

    George Corsiglia

    George Corsiglia, Senior Strategist, Strategy and Consultation Group, BBK Worldwide

    clock

    9:10

    PAEDIATRIC CLINICAL TRIALS

    E. David McIntosh

    E. David McIntosh, Honorary Clinical Senior Lecturer, Imperial College

  • Waivers and deferrals
  • Update on inventory of needs
  • Networks and their benefits
  • Extrapolation using pharmacology
  • Paediatric biomarkers and surrogate markers
  • clock

    9:50

    CLINICAL TRIAL REGISTRATION

  • Keys to success
  • EU versus US requirements
  • Ways to minimise the associated risks
  • Louis-Christian Clauss

    Louis-Christian Clauss, General Co-Ordinator for Clinical and Regulatory, LFB Biotechnologies

    clock

    10:30

    Morning Coffee

    clock

    11:00

    STATISTICAL MODELLING

    Vladimir Anisimov

    Vladimir Anisimov, Director, Research Statistics Unit, GlaxoSmithKline

  • Main sources of uncertainty
  • Modelling and predicting recruitment at the design and interim stages
  • Assessing the number of clinical centres and adaptive adjustment
  • Predicting study performance and site productivity
  • Randomization issues in CT, impact on supply chain
  • Statistical modelling of drug supply
  • Case studies
  • clock

    11:40

    CLINICAL TRIAL SIMULATION

    Hermann Kulmann

    Hermann Kulmann, Senior Director, Global Biostatistics, Bayer Schering Pharma

  • Small number of centres with dissimilar recruitment rates
  • Inhomogeneous patient population
  • Interim analysis
  • Prediction of completers
  • Cost estimation
  • clock

    12:20

    Networking Lunch

    clock

    13:50

    KEYNOTE PRESENTATION: ADAPTIVE TRIAL DESIGN

    Fiona Guillard

    Fiona Guillard, Manager, Statistics, GlaxoSmithkline

  • Advantages and disadvantages of an adaptive design
  • Considerations for an adaptive design
  • Design development and the role of simulation
  • Randomisation process
  • Regulatory aspects
  • Interpreting the results and decisions
  • clock

    14:30

    EMERGENCY MEDICAL RESPONSE FOR CLINICAL TRIALS

    Rita Fitzpatrick

    Rita Fitzpatrick, Head of Emergency Scientific and Medical Services, Guy's And St Thomas' NHS Foundation Trust

  • Emergency medical response options
  • Emergency unblinding criteria and procedures
  • Adverse event management
  • clock

    15:10

    Afternoon Tea

    clock

    15:40

    CONDUCTING PAEDIATRIC CLINICAL TRIALS

    Suzana Radulovic

    Suzana Radulovic, Clinical Research Fellow , Kings College London

  • Background – the paediatric regulation
  • Ethical aspects of paediatric clinical trials
  • Clinical and practical aspects of paediatric clinical trials
  • Results of a feasibility study
  • clock

    16:20

    CLARIFYING THE ROLE AND DUTIES OF THE CLINICAL SUPPLIES COORDINATOR

  • The role of the clinical supplies co-ordinator
  • The challenges faced in this role
  • Coordinating the manufacture and supply of clinical materials
  • Liaising with external facilities
  • Conclusions
  • Martin Kristiansen

    Martin Kristiansen, Clinical Supplies Project Coordinator , Novo Nordisk

    Marianne Hansen

    Marianne Hansen, Clinical Supplies Project Coordinator, Novo Nordisk

    clock

    17:00

    Chairman’s Closing Remarks and Close of Conference

    Workshops

    The Safety Aspects of Clinical Trial Reporting in the EU

    The Safety Aspects of Clinical Trial Reporting in the EU

    Crowne Plaza Hotel - St James
    14 October 2009
    London, United Kingdom

    VENUE

    Crowne Plaza Hotel - St James

    Buckingham Gate 45/51, London, United Kingdom

    A number of our clients have been approached by third party organisations offering to book hotel rooms. We would advise that you do not book through them as they are not representing the SMi Group. SMi Group books all hotel rooms directly. If you are approached by a third party organisation then please contact us before making any bookings. If you have already booked a hotel room using a third party organisation, we would highly recommend contacting the hotel you were booked into to ensure a booking has been made for you. We would also advise you to please check the terms and conditions of the booking carefully.
    HOTEL BOOKING FORM

    SAVE TO


    Outlook Calendar  OUTLOOK CALENDAR
    Google Calendar  GOOGLE CALENDAR
    ICal Calendar  ICAL CALENDAR
    Yahoo! Calendar  YAHOO! CALENDAR

    Crowne Plaza Hotel - St James

    Buckingham Gate 45/51
    London SW1E 6AF
    United Kingdom

    Crowne Plaza Hotel - St James

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download

    Title


    Description

    Download

    Title


    Description


    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SAE Media Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@saemediagroup.com

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    Group Booking

    Please complete the below form and a member of SAE Media Group’s booking team will be in contact within 24 hours

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SAE Media Group

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SAE Media Group , Ground Floor, India House, 45 Curlew Street, London, SE1 2ND, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smgconferences.com Email: events@saemediagroup.com
    Registered in England - SMi Group Ltd trading as SAE Media Group




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.

    Thank you for visiting our event

    If you would like to receive further information about our events, please fill out the information below.

    By ticking above you are consenting to receive information by email from SAE Media Group.
    Full details of our privacy policy can be found here https://www.smgconferences.com/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data.privacy@smgconferences.com.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smgconferences.com/opt-out

    Fill in your details to download the brochure

    By submitting this form you agree to our privacy policy and consent to receiving communications, you may opt out at any time.